M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations
Maravai Lifesciences Holdings, Inc. to acquire MyChem
Announced Jan 28, 2022 · Closed Jan 28, 2022 · Private target
Deal value$240M
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationAll cash
Transaction
- Acquirer
- Maravai Lifesciences Holdings, Inc. (MRVI)
- Target
- MyChem
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Jan 28, 2022
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Jefferies
- To the target
- Not disclosed
Classification
- Sector
- Healthcare
- Buyer's industry
- Pharmaceutical Preparations